Cicala S, de Simone G, Gerdts E, Dahlöf B, Lindholm LH, Kjeldsen SE, Devereux RB. Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens. 2010 Jun;28(6):1134–40. PMID: 20486280.
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study